Lone	lone	O	O	O	O
atrial	atrial	O	DISEASE	OTHERS	I
fibrillation	fibrillation	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
creatine	creatine	CHEMICALS	O	OTHERS	I
monohydrate	monohydrate	O	O	O	O
supplementation	supplementation	O	O	O	O
.	.	O	O	O	O

Atrial	atrial	O	DISEASE	OTHERS	I
fibrillation	fibrillation	O	DISEASE	OTHERS	I
in	in	O	O	O	O
young	young	O	O	O	O
patients	patients	O	O	O	O
without	without	O	O	O	O
structural	structural	O	O	O	O
heart	heart	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
is	is	O	O	O	O
rare	rare	O	O	O	O
.	.	O	O	O	O

Therefore	therefore	O	O	O	O
,	,	O	O	O	O
when	when	O	O	O	O
the	the	O	O	O	O
arrhythmia	arrhythmia	O	DISEASE	OTHERS	I
is	is	O	O	O	O
present	present	O	O	O	O
in	in	O	O	O	O
this	this	O	O	O	O
population	population	O	O	O	O
,	,	O	O	O	O
reversible	reversible	O	O	O	O
causes	causes	O	O	O	O
must	must	O	O	O	O
be	be	O	O	O	O
identified	identified	O	O	O	O
and	and	O	O	O	O
resolved	resolved	O	O	O	O
.	.	O	O	O	O

Thyroid	thyroid	O	O	OTHERS	I
disorders	disorders	O	O	OTHERS	I
,	,	O	O	O	O
illicit	illicit	O	O	O	O
drug	drug	O	O	O	O
or	or	O	O	O	O
stimulant	stimulant	O	O	O	O
use	use	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
acute	acute	O	O	OTHERS	I
alcohol	alcohol	CHEMICALS	O	OTHERS	I
intoxication	intoxication	O	O	OTHERS	I
are	are	O	O	O	O
among	among	O	O	O	O
these	these	O	O	O	O
causes	causes	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
the	the	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
30-year-old	30-year-old	O	O	O	O
Caucasian	caucasian	O	O	O	O
man	man	O	O	O	O
who	who	O	O	O	O
came	came	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
emergency	emergency	O	O	OTHERS	I
department	department	O	O	OTHERS	I
in	in	O	O	O	O
atrial	atrial	O	DISEASE	OTHERS	I
fibrillation	fibrillation	O	DISEASE	OTHERS	I
with	with	O	O	O	O
rapid	rapid	O	O	O	O
ventricular	ventricular	O	O	O	O
response	response	O	O	O	O
.	.	O	O	O	O

His	his	O	O	O	O
medical	medical	O	O	O	O
history	history	O	O	O	O
was	was	O	O	O	O
unremarkable	unremarkable	O	O	O	O
,	,	O	O	O	O
except	except	O	O	O	O
for	for	O	O	O	O
minor	minor	O	O	O	O
fractures	fractures	O	DISEASE	OTHERS	I
of	of	O	O	O	O
the	the	O	O	O	O
fingers	fingers	O	O	O	O
and	and	O	O	O	O
foot	foot	O	O	O	O
.	.	O	O	O	O

Thyroid-stimulating	thyroid-stimulating	O	O	O	O
hormone	hormone	O	O	O	O
,	,	O	O	O	O
magnesium	magnesium	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
potassium	potassium	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
were	were	O	O	O	O
within	within	O	O	O	O
normal	normal	O	O	O	O
limits	limits	O	O	O	O
,	,	O	O	O	O
urine	urine	O	O	O	O
drug	drug	O	O	O	O
screen	screen	O	O	O	O
was	was	O	O	O	O
negative	negative	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
alcohol	alcohol	CHEMICALS	O	OTHERS	I
use	use	O	O	O	O
was	was	O	O	O	O
denied	denied	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
when	when	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
questioned	questioned	O	O	O	O
about	about	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
herbal	herbal	O	O	O	O
products	products	O	O	O	O
and	and	O	O	O	O
supplements	supplements	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
creatine	creatine	CHEMICALS	O	OTHERS	I
monohydrate	monohydrate	O	O	O	O
was	was	O	O	O	O
revealed	revealed	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
admitted	admitted	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
hospital	hospital	O	O	O	O
,	,	O	O	O	O
anticoagulated	anticoagulated	O	O	O	O
with	with	O	O	O	O
unfractionated	unfractionated	O	O	OTHERS	I
heparin	heparin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
given	given	O	O	O	O
intravenous	intravenous	O	O	O	O
diltiazem	diltiazem	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
rate	rate	O	O	O	O
control	control	O	O	O	O
and	and	O	O	O	O
intravenous	intravenous	O	O	O	O
amiodarone	amiodarone	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
rate	rate	O	O	O	O
and	and	O	O	O	O
rhythm	rhythm	O	O	O	O
control	control	O	O	O	O
.	.	O	O	O	O

When	when	O	O	O	O
discharged	discharged	O	O	O	O
less	less	O	O	O	O
than	than	O	O	O	O
24	24	O	O	O	O
hours	hours	O	O	O	O
later	later	O	O	O	O
,	,	O	O	O	O
he	he	O	O	O	O
was	was	O	O	O	O
receiving	receiving	O	O	O	O
metoprolol	metoprolol	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
aspirin	aspirin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
with	with	O	O	O	O
follow-up	follow-up	O	O	O	O
plans	plans	O	O	O	O
for	for	O	O	O	O
echocardiography	echocardiography	O	O	O	O
and	and	O	O	O	O
nuclear	nuclear	O	O	O	O
imaging	imaging	O	O	O	O
to	to	O	O	O	O
assess	assess	O	O	O	O
perfusion	perfusion	O	O	O	O
.	.	O	O	O	O

Exogenous	exogenous	O	O	O	O
creatine	creatine	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
used	used	O	O	O	O
by	by	O	O	O	O
athletes	athletes	O	O	O	O
to	to	O	O	O	O
theoretically	theoretically	O	O	O	O
improve	improve	O	O	O	O
exercise	exercise	O	O	O	O
performance	performance	O	O	O	O
.	.	O	O	O	O

Vegetarians	vegetarians	O	O	O	O
may	may	O	O	O	O
also	also	O	O	O	O
take	take	O	O	O	O
creatine	creatine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
replace	replace	O	O	O	O
what	what	O	O	O	O
they	they	O	O	O	O
are	are	O	O	O	O
not	not	O	O	O	O
consuming	consuming	O	O	O	O
from	from	O	O	O	O
meat	meat	O	O	O	O
,	,	O	O	O	O
fish	fish	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
other	other	O	O	O	O
animal	animal	O	O	O	O
products	products	O	O	O	O
.	.	O	O	O	O

Previous	previous	O	O	O	O
anecdotal	anecdotal	O	O	O	O
reports	reports	O	O	O	O
have	have	O	O	O	O
linked	linked	O	O	O	O
creatine	creatine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
the	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
arrhythmia	arrhythmia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Clinicians	clinicians	O	O	O	O
must	must	O	O	O	O
be	be	O	O	O	O
diligent	diligent	O	O	O	O
when	when	O	O	O	O
interviewing	interviewing	O	O	O	O
patients	patients	O	O	O	O
about	about	O	O	O	O
their	their	O	O	O	O
drug	drug	O	O	O	O
therapy	therapy	O	O	O	O
histories	histories	O	O	O	O
and	and	O	O	O	O
include	include	O	O	O	O
questions	questions	O	O	O	O
about	about	O	O	O	O
their	their	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
herbal	herbal	O	O	O	O
products	products	O	O	O	O
and	and	O	O	O	O
dietary	dietary	O	O	O	O
supplements	supplements	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
addition	addition	O	O	O	O
,	,	O	O	O	O
it	it	O	O	O	O
is	is	O	O	O	O
important	important	O	O	O	O
to	to	O	O	O	O
report	report	O	O	O	O
adverse	adverse	O	O	O	O
effects	effects	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
frequently	frequently	O	O	O	O
consumed	consumed	O	O	O	O
supplements	supplements	O	O	O	O
and	and	O	O	O	O
herbal	herbal	O	O	O	O
products	products	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
Food	food	O	O	O	O
and	and	O	O	O	O
Drug	drug	O	O	O	O
Administration	administration	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
literature	literature	O	O	O	O
.	.	O	O	O	O

